TrialNeuro-oncology2014

Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.

James G Gurney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.